{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-046545","form_type":"8-K","ticker":"EXOZ","cik":"0002010788","company_name":"EXOZYMES INC.","filed_at":"2024-11-18T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.560729+00:00","generated_at":"2026-05-29T23:17:50.365583+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Invizyne completes $15M IPO; shares begin trading on Nasdaq under IZTC","bullets":["Priced 1,875,000 shares at $8.00; gross proceeds $15M, net proceeds ~$14.3M.","Concurrent private placement issued 93,750 warrants at $0.125, exercisable at $8.00 for 5 years.","Underwriter has 45-day option to purchase up to 281,250 additional shares for over-allotments.","Net proceeds to fund production capacity, business development, repayment of related-party loan, and working capital.","SAFEs from July 2023 converted into 125,001 shares of common stock upon IPO closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-046545","json":"https://secwatch.observer/filing/0001493152-24-046545.json","markdown":"https://secwatch.observer/filing/0001493152-24-046545.md","text":"https://secwatch.observer/filing/0001493152-24-046545.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2010788/000149315224046545/0001493152-24-046545-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2010788/000149315224046545/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T23:17:50.365583+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}